Your institution may have access to this item. Find your institution then sign in to continue.
Title
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction.
Authors
Papp, K A; Tyring, S; Lahfa, M; Prinz, J; Griffiths, C E M; Nakanishi, A M; Zitnik, R; van de Kerkhof, P C M; Melvin, Linda; Etanercept Psoriasis Study Group
Abstract
In previous studies, etanercept significantly improved plaque psoriasis and was well tolerated.
Publication
The British journal of dermatology, 2005, Vol 152, Issue 6, p1304